A conversation with Brian M. Overstreet, founder and president of Adverse Events, Inc., about the challenges FDA faces in reporting adverse drug events to the public and the impact on patient safety.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.